The efficacy of propranolol in very preterm infants at the risk of retinopathy of prematurity: Which newborn and when?

[1] Fierson WM(2013)American Academy of Pediatrics Section on Ophthalmology; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus; American Association of Certified Orthoptists. Screening examination of premature infants for retinopathy of prematurity Pediatrics 131 189-195

[2] Ristori C(2011)Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta adrenoreceptor blockade Invest Ophthalmol Vis Sci 52 155-170

[3] Filippi L(2011)Antiangiogenic effects of β J Neurochem 119 1317-1329

[4] Dal Monte M(2016)-adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy Curr Eye Res 3 1-10

[5] Martini D(2013)The efficacy of propranolol in retinopathy of prematurity and its correlation with the platelet mass index Arch Dis Child Fetal Neonatal Ed 98 454-456

[6] Cammalleri M(2017)Management of retinopathy of prematurity Front Immunol 22 1868-119

[7] Fortunato P(2018)Abnormal complement activation and inflammation in the pathogenesis of retinopathy of prematurity Prog Retin Eye Res 62 77-934

[8] Martini D(2002)Pathophysiology, screening and treatment of ROP: a multi-disciplinary perspective Ophthalmology 109 928-456

[9] Monte MD(2010)A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 1. Visual function and structural outcome Turk J Pediatr 52 450-1492

[10] Ristori C(2010)Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants Pediatrics 125 1483-133

[1] Fierson WM(2013)American Academy of Pediatrics Section on Ophthalmology; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus; American Association of Certified Orthoptists. Screening examination of premature infants for retinopathy of prematurity Pediatrics 131 189-195

[2] Ristori C(2011)Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta adrenoreceptor blockade Invest Ophthalmol Vis Sci 52 155-170

[3] Filippi L(2011)Antiangiogenic effects of β J Neurochem 119 1317-1329

[4] Dal Monte M(2016)-adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy Curr Eye Res 3 1-10

[5] Martini D(2013)The efficacy of propranolol in retinopathy of prematurity and its correlation with the platelet mass index Arch Dis Child Fetal Neonatal Ed 98 454-456

[6] Cammalleri M(2017)Management of retinopathy of prematurity Front Immunol 22 1868-119

[7] Fortunato P(2018)Abnormal complement activation and inflammation in the pathogenesis of retinopathy of prematurity Prog Retin Eye Res 62 77-934

[8] Martini D(2002)Pathophysiology, screening and treatment of ROP: a multi-disciplinary perspective Ophthalmology 109 928-456

[9] Monte MD(2010)A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 1. Visual function and structural outcome Turk J Pediatr 52 450-1492

[10] Ristori C(2010)Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants Pediatrics 125 1483-133